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Homoleptic tin(IV) compounds containing tridentate ONS dithiocarbazate Schiff bases: 




Six new tin(IV) compounds derived from tridentate dinegatively charged ONS dithiocarbazate 
Schiff bases derived from 2-hydroxy-3-methoxybenzaldehyde (H2L1, H2L2 and H2L3) and 2,3-
dihydroxybenzaldehyde (H2L4, H2L5 and H2L6) (where H2Ln = di-acids of Schiff base) are 
reported. The compounds were characterised by elemental analysis, FT-IR and multinuclear NMR 
(1H, 13C and 119Sn) spectroscopy. The crystal structures of tin(IV) [S-4-methybenzyl-β-N-(2-
hydroxy-3-methoxybenzylmethylene)dithiocarbazate] (2) and tin(IV) [S-benzyl-β-N-(2-hydroxy-
3-methoxy benzylmethylene)dithiocarbazate] (3) were determined by X-ray single crystal 
diffraction analysis. X-ray crystallography showed the molecular geometries in homoleptic 2 and 
3 to be quite similar in which the dinegative tridentate ligand coordinated the tin atoms via thiolate-
S, phenoxide-O and imine-N atoms. The coordination geometries are based on an octahedron with 
like-atoms mutually trans. The experimental findings were validated by density functional theory 
(DFT) calculations at the B3LYP/LanL2DZ/6-311G(d,p) level of theory. All the tin(IV) 
compounds, except the insoluble compound 2 were screened for their in vitro cytotoxicity against 
a panel ten of cancer cell lines and one normal breast cell line (MCF-10 A) by MTT assay. 
Interestingly, the cytotoxicity of five tin(IV) compounds against HT29, MCF7 and MIA was 
higher than the reference drug, cisplatin. 
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